Changming An

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0002-8353-4547

发表论文 161 篇 · 总被引 1460 次 · h-index 19

代表论文

• Covalent FAPI Imaging–Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial (2026 · Clinical Cancer Research · 被引 1)
• Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma (2026)
• Supplementary Figure S1 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study (2026)
• Supplementary Table 9 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma (2026)
• Supplementary Figure S2 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study (2026)
• Supplementary Figure S4 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study (2026)